about
Clinical Practice Guideline: TinnitusNeurotoxins: free radical mechanisms and melatonin protectionMelatonin has multiorgan effectsBedtime and evening light exposure influence circadian timing in preschool-age children: A field studyMelatonin suppresses hypoxia-induced migration of HUVECs via inhibition of ERK/Rac1 activation.Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humansMelatonin attenuates the vestibulosympathetic but not vestibulocollic reflexes in humans: selective impairment of the utricles.Treatment of central and sensorineural tinnitus with orally administered Melatonin and Sulodexide: personal experience from a randomized controlled study.Dietary Sources and Bioactivities of MelatoninSleep duration as a risk factor for cardiovascular disease- a review of the recent literatureHypertension and cardiovascular remodelling in rats exposed to continuous light: protection by ACE-inhibition and melatonin.Restoration of asymmetric dimethylarginine-nitric oxide balance to prevent the development of hypertension.The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertensionPeripheral and central effects of melatonin on blood pressure regulationTranscriptional regulation of programmed hypertension by melatonin: an epigenetic perspective.Melatonin: can it stop the ringing?Potency of melatonin in living beingsAlteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy.Metabolomics analysis reveals insights into biochemical mechanisms of mental stress-induced left ventricular dysfunction.Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review.Maternal Melatonin Therapy Rescues Prenatal Dexamethasone and Postnatal High-Fat Diet Induced Programmed Hypertension in Male Rat OffspringMelatonin modulates baroreflex control via area postremaThe role of plasma melatonin and vitamins C and B12 in the development of idiopathic tinnitus in the elderly.Circadian rhythm connections to oxidative stress: implications for human health.Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance.Cardiovascular diseases: protective effects of melatonin.Melatonin and reproduction revisited.The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgeryManagement of nocturnal hypertension.Endothelium and its alterations in cardiovascular diseases: life style intervention.Developmental Programming of Adult Disease: Reprogramming by Melatonin?Melatonin attenuates angiotensin II-induced abdominal aortic aneurysm through the down-regulation of matrix metalloproteinases.Beneficial effects of melatonin in cardiovascular disease.The physiological roles of phosducin: from retinal function to stress-dependent hypertension.Potential utility of melatonin as an antioxidant during pregnancy and in the perinatal period.Cardiovascular effects of melatonin receptor agonists.Melatonin and metabolic regulation: a review.Melatonin: a "Higgs boson" in human reproduction.Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds.Effects of melatonin on cardiovascular diseases: progress in the past year
P2860
Q22241833-CD473C08-A2C5-4112-8F7B-194004410BF5Q22305781-D36A9891-370A-45B9-996A-B626F6366C00Q28077901-9C26CF7A-BCDE-4AF2-B7D6-05B8728C2EDAQ28397414-376B64FA-8A47-4CFD-A385-73126F970BE0Q30410662-00EE9A57-3F74-4CCF-864E-51CEB18B2A13Q30428120-6E2D315D-7EE8-4A13-A9B9-EAD152A6D1E1Q30472567-C72B415A-5358-49BE-B4BF-37ADA5B928DDQ33599887-2B072B0F-4CE7-4A28-9AE5-0ED7CEC9F05BQ33616780-7F31FAAC-D64C-447B-A788-C4255103F659Q33754184-7E5E6716-18D0-4BBD-87AE-C8560390F9D7Q33930296-37E41018-28D9-4D4A-8430-1D8679CE3CF2Q34072296-949EDDCB-8F26-46AC-93D0-65111048A72CQ34247221-F1F0CA57-8B57-4243-83A3-EC7EABCE2757Q34486692-19D78F73-43E6-4C82-902C-7ABC53A54D64Q34486865-5277A493-BB7F-4B5E-A53C-E608660C474AQ34631774-8D49F03D-0A40-4DCE-AAC4-C3A1A7327647Q34804952-0B3EC2A1-DB8E-42E3-A8C7-AA619D302564Q35015863-ACFC9F46-4C61-485F-A39B-F0A991D12B91Q35606621-BE0F7675-8742-4850-8D1D-7F2A63415A5EQ36041575-CDFFBF5B-D9F1-4D4D-8FB7-EA4ADC2C59FCQ36363471-F7B96868-9441-4118-8525-CFA28946AC9DQ36713140-0464EE59-C581-42B9-BC25-E875DD9C15F1Q36818870-816097E1-01BF-43F7-86B1-EE4289876938Q36945752-E571D013-7FB2-41B3-A302-BFE39C707D92Q36957964-26EAE931-12B5-48A9-97F6-8FA20EBC6BE5Q37031598-136D6462-71C0-4C93-8A2E-FDE1FF6CC1E2Q37480368-8BEB3B80-E81B-460F-AC5B-C0E45205AE32Q37504626-9F36DBB5-0652-435F-9C3B-8683009832EFQ37510981-9AEA4A53-0592-42DE-933F-277E65655C7AQ37639902-593AE430-44FD-420A-9780-B7CDCC436C4CQ37691012-D903CFCB-E5C5-45CB-A986-E4CB2F875AD6Q37716360-142B23AA-FB07-416D-A5C0-A75AB0676B67Q37747491-E13B4747-BFA7-4C5F-8302-E52C69A37474Q37808650-9C9FB4C4-1C09-4D25-89D5-828A1B81305CQ37873941-6CBB4B87-4770-4B18-B3AE-AD5133326994Q38037124-BB2C7853-0A3B-46E4-B709-A8B07FBFC237Q38248106-F7E1E6FF-F5F7-4135-A6BE-5593CDE5923CQ38265922-16B2F2DF-4B04-4698-8A46-1ECC7F3B3953Q38747526-B06B63DA-95EF-406D-BFFB-DFA9614017DCQ38807607-D1A09252-0D44-4E8C-8A52-A5F1E43C2092
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Melatonin as a potential antihypertensive treatment.
@ast
Melatonin as a potential antihypertensive treatment.
@en
type
label
Melatonin as a potential antihypertensive treatment.
@ast
Melatonin as a potential antihypertensive treatment.
@en
prefLabel
Melatonin as a potential antihypertensive treatment.
@ast
Melatonin as a potential antihypertensive treatment.
@en
P2860
P1476
Melatonin as a potential antihypertensive treatment.
@en
P2093
Fedor Simko
P2860
P304
P356
10.1111/J.1600-079X.2007.00436.X
P577
2007-04-01T00:00:00Z